Metraipolis › archive › dc_deed797cfbaa
Real-world response rates in patients with human epidermal growth factor receptor 2-positive breast cancer after neoadjuvant treatment using dual human… — Europe PMC PMID:42780385
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42780385
- DOI
- 10.3389/fonc.2026.1895998
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T20:49:00.869Z
- SHA-256 of the archived text
9873f469d80114e96d8ea6048f63b6b3cd3f01b55bdae8735d68ad12cfa24474- Stable URL of this page
https://metraipolis.com/documento/dc_deed797cfbaa
How to cite
Real-world response rates in patients with human epidermal growth factor receptor 2-positive breast cancer after neoadjuvant treatment using dual human… — Europe PMC PMID:42780385 — Europe PMC (en), https://europepmc.org/article/MED/42780385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_deed797cfbaa (Metraipolis archive dc_deed797cfbaa, sha256 9873f469d80114e96d8ea6048f63b6b3cd3f01b55bdae8735d68ad12cfa24474)
BibTeX
@misc{dcdeed797cfbaa,
title = {Real-world response rates in patients with human epidermal growth factor receptor 2-positive breast cancer after neoadjuvant treatment using dual human… — Europe PMC PMID:42780385},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42780385},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_deed797cfbaa; sha256 9873f469d80114e96d8ea6048f63b6b3cd3f01b55bdae8735d68ad12cfa24474},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42780385. Agents can read the archived copy with the MCP tool read_document.